Glaucoma and corneal neovascularization which is the world leading eye disease
could be given new
treatment options by use of tiny microneedles which are
small enough to an unaided eye. One of the
leading causes of blindness is glaucoma, which happens
when untreated and corneal
neovascularization, causes an additional growth of
blood vessels that damage the vision. Due to the
barrier and relative accessibility of the ocular
tissue, treating the anterior and posterior segment of the
eye disease is highly challenging. Development of
microneedle-based systems is being experimented
with a way where the drug is precisely put into the
part of the eye. Microneedles range in length from
400-700 µm could provide a better medium of drug
delivery into the eyes and thereby better disease
management. The microneedle technology of drug delivery
will be target specific to the eye and
thereby leading to the decrease the quantity of the
drug and increasing the effectiveness with minimal
side effects. Thus, coupling this delivery with a
controlled release formulation may allow treating a
condition for weeks or months. Thus, this review
elucidates on the current research, new technologies
and the design which may act as a potential treatment
for retinal disease.
Author(s) Details
Ms. Baishali A Jana
Department of Pharmaceutical Biotechnology, JSS Academy of Higher
Education and Research, JSS College of Pharmacy, Ooty - 643001, Tamil Nadu, The
Nilgiris, India.
Ashish D. Wadhwani
Department of Pharmaceutical Biotechnology, JSS Academy of Higher
Education and Research, JSS College of Pharmacy, Ooty - 643001, Tamil Nadu, The
Nilgiris, India.
View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/222
No comments:
Post a Comment